2017/05/22 by Victor Bustos, Maria V. Pulina, Ashley Bispo +5 · 25 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Cellular transport and secretion #Alzheimer's disease research and treatments #Autophagy in Disease and Therapy
paper · pdf · doi:10.1073/pnas.1705240114
Significance Autophagy is a catabolic process involving the formation of double-membrane–bound organelles called autophagosomes, which participate in the degradation of intracellular material through fusion with lysosomes. We have found a level of regulation of autophagosomal–lysosomal fusion where Presenilin 1 (PS1) phosphorylated at Ser367 specifically binds Annexin A2, which, through successive binding steps, facilitates this fusion. Lack of phosphorylation on PS1 1 Ser367 causes accumulation of partially fused autophagosomes and lysosomes in mouse brain and reduced autophagic flux. This inhibition of autophagy leads to decreased βCTF degradation and accumulation of toxic Aβ-peptide in the brain. This signaling pathway offers new potential drug targets for Alzheimer’s disease.